NCT02298335View on ClinicalTrials.gov

Glucocorticoid in Treatment of Adult Idiopathic Nephrotic Syndrome：a Prospective Observational Study

NACompletedINTERVENTIONAL

Enrollment

235

Participants

Timeline

Start Date

May 13, 2014

Primary Completion Date

July 31, 2019

Study Completion Date

October 22, 2020

Conditions

Nephrotic Syndrome，Idiopathic

Interventions

DRUG

prednisone

Full-dose induction period: Prednisone 1mg/kg.day, maximum 60mg/day, orally, divided into 3 times; Protracted tapering period: orally, no ask for fract. dos.

Trial Locations (1)

210000

Research Institute of Nephrology, Nanjing

All Listed Sponsors

lead

Nanjing University School of Medicine

OTHER

NCT02298335 - Glucocorticoid in Treatment of Adult Idiopathic Nephrotic Syndrome：a Prospective Observational Study | Biotech Hunter | Biotech Hunter